We are live on ! Find out more
CHTP

CHELSEA THERAPEUTICS INT'L LTD
CHTP

Delisted

CHTP was delisted on the 23rd of June, 2014.

Back to rankings

61 hedge funds and large institutions have $56.3M invested in CHELSEA THERAPEUTICS INT'L LTD in 2013 Q2 according to their latest regulatory filings, with 61 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

66% less call options, than puts

Call options by funds: $263K | Put options by funds: $778K

Holders
61
Holders Change
+61
Holders Change %
–
% of All Funds
1.99%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
61
Increased
–
Reduced
–
Closed
–
Calls
$263K
Puts
$778K
Net Calls
-$515K
Net Calls Change
-$515K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$235K +$206K +102,103 New
Charles Schwab
27
Charles Schwab
California
$230K +$193K +95,600 New
TA
28
Teachers Advisors
New York
$198K +$174K +86,243 New
HCMT
29
Highland Capital Management (Texas)
Texas
$184K +$162K +80,000 New
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$143K +$126K +62,230 New
JP Morgan Chase
31
JP Morgan Chase
New York
$139K +$122K +60,387 New
Manulife (Manufacturers Life Insurance)
32
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$126K +$111K +54,942 New
T. Rowe Price Associates
33
T. Rowe Price Associates
Maryland
$109K +$95.6K +47,300 New
KCG
34
Knight Capital Group
$108K +$95.1K +47,056 New
Marshall Wace
35
Marshall Wace
United Kingdom
$104K +$91.2K +45,100 New
OAM
36
Oxford Asset Management
United Kingdom
$102K +$89.3K +44,160 New
BA
37
BlackRock Advisors
Delaware
$92K +$81K +40,073 New
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$82K +$71.7K +35,469 New
AllianceBernstein
39
AllianceBernstein
Tennessee
$78K +$68.2K +33,748 New
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
$67.3K +$59.2K +29,277 New
Barclays
41
Barclays
United Kingdom
$65K +$57.8K +28,574 New
Two Sigma Investments
42
Two Sigma Investments
New York
$64K +$55.8K +27,595 New
EEG
43
E.E. Geduld
$58K +$50.5K +25,000 New
JG
44
Jefferies Group
New York
$51K +$44.6K +22,068 New
NFA
45
Nationwide Fund Advisors
Ohio
$49K +$43.4K +21,458 New
PCM
46
Prelude Capital Management
New York
$48K +$42.5K +21,000 New
GC
47
Guggenheim Capital
Illinois
$42K +$36.8K +18,203 New
PA
48
Pinnacle Associates
New York
$32K +$28.3K +14,000 New
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$31K +$27K +13,343 New
CS
50
Credit Suisse
Switzerland
$30K +$26.8K +13,244 New
1
2
3

CHTP Hedge Fund Activity: Q2 2013 in Review

61 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in CHELSEA THERAPEUTICS INT'L LTD (CHTP) for Q2 2013, worth a combined $56.3M.

Buyers outnumbered sellers: 61 funds opened new CHTP positions and 0 closed out — a net gain of 61 holders — while 0 added to existing stakes and 0 trimmed.

  • 61 institutional investors held CHELSEA THERAPEUTICS INT'L LTD (CHTP) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $56.3M of CHELSEA THERAPEUTICS INT'L LTD stock for Q2 2013.
  • 61 funds opened new CHELSEA THERAPEUTICS INT'L LTD positions in Q2 2013 and 0 closed out, a net change of +61 holders.

Based on aggregated 13F filings for Q2 2013.